Back to top

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. on July 17 and set a price target of $49.41. The company’s shares ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: